MARX Biotech Co (ROCO:7731) Research & Development: NT$0.3 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
10 GF Score
Price NT$4.87
! 4 Warning Signs
View Full Analysis

What is MARX Biotech Co Research & Development?

MARX Biotech Co ROCO:7731 -3.18% 10 Research & Development is NT$0.3 Mil as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. MARX Biotech Co's Research & Development for the six months ended in Dec. 2025 was NT$0.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.3 Mil.

MARX Biotech Co  (ROCO:7731) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MARX Biotech Co Research & Development Related Terms

MARX Biotech Co Research & Development Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Research & Development Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.74 25.99 0.32

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.88 25.12 0.24 0.08
ROCO:7731
10GF Score
MARX Biotech Co Ltd ROCO:7731
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$0.3 Mil mean?
MARX Biotech Co (ROCO:7731) has a Research & Development of NT$0.3 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Research & Development too high?
MARX Biotech Co's current Research & Development is NT$0.3 Mil. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Research & Development compare to competitors?
MARX Biotech Co's Research & Development of NT$0.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Research & Development is NT$0.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Research & Development of NT$0.3 Mil. The current Research & Development is NT$0.3 Mil. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Research & Development is NT$0.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score

Get the complete analysis for ROCO:7731

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.87
Price